# Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous

> **NCT01429701** · PHASE3 · COMPLETED · sponsor: **EMS** · enrollment: 76 (actual)

## Conditions studied

- Eczema

## Interventions

- **DRUG:** polymyxin B sulphate + prednisolone + benzocaine + clioquinol
- **DRUG:** betamethasone + gentamicin + tolnaftato + cleoquinol

## Key facts

- **NCT ID:** NCT01429701
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-08
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2021-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429701, "Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01429701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*